Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | HCAR2 | Q8TDS4 | 7/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 5/20 | 0.35 |
| ▸ | PRKCA | P17252 | 2/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28667982 | 1.00 | ATM (0.59) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL4630430 | 1.00 | ATM (0.59) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL3482636 | 0.92 | HCAR2 (0.65) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9239918 | 0.92 | ATM (0.52) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9239892 | 0.92 | ATM (0.57) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL3482645 | 0.92 | HCAR2 (0.65) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9239900 | 0.92 | ATM (0.57) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9239929 | 0.92 | ATM (0.52) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL332045 | 0.90 | ATM (0.48) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9239882 | 0.89 | HCAR2 (0.67) | ATMHCAR2MAPTRAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12428390-B2 | Chromene compound and photochromic optical article | TOKUYAMA CORPORATION (JP) | 2025-09-30 | — | — | US | disclosed |
| EP-3822296-B1 | POLYMER MATERIAL | MENICON CO LTD (JP) | 2025-09-10 | — | — | EP | disclosed |
| WO-2025094241-A1 | COMPOSITE MEMBRANE | 株式会社メニコン | 2025-05-08 | — | — | WO | disclosed |
| US-20250115701-A1 | POLYMER MATERIAL | MENICON CO., LTD. (JP) | 2025-04-10 | — | — | US | disclosed |
| US-12209154-B2 | Polymer material | MENICON CO., LTD. (JP) | 2025-01-28 | — | — | US | disclosed |
| EP-3995493-B1 | CHROMENE COMPOUND AND PHOTOCHROMIC OPTICAL ARTICLE | TOKUYAMA CORP (JP) | 2024-07-03 | — | — | EP | disclosed |
| CN-114051497-B | Chromene compounds and photochromic optical articles | 株式会社德山 | 2024-06-28 | — | — | CN | disclosed |
| US-20240026145-A1 | OPHTHALMIC LENS | MENICON CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| EP-4206797-A1 | OPHTHALMIC LENS | Menicon Co., Ltd. (JP) | 2023-07-05 | — | — | EP | disclosed |
| CN-115997158-A | Ophthalmic lens | 株式会社目立康 | 2023-04-21 | — | — | CN | disclosed |
| EP-0219884-B1 | HARD CONTACT LENS MATERIAL | Tomei Sangyo Kabushiki Kaisha (JP) | 1993-09-29 | — | — | EP | disclosed |
| US-5206298-A | GRAFT COPOLYMER, SOLUTION CONTAINING THE GRAFT COPOLYMER FOR TREATING CONTACT LENS, AND METHOD OF TREATING CONTACT LENS WITH THE SOLUTION AND MAKING HYDROPHILIC LENS SURFACE | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1993-04-27 | — | — | US | disclosed |
| EP-0524557-A2 | Ocular lens material | Menicon Co., Ltd. (JP) | 1993-01-27 | — | — | EP | disclosed |
| US-5142009-A | Crosslinked blend of fumaric acid diesters | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1992-08-25 | — | — | US | disclosed |
| US-5134213-A | N-Vinyllactam-Monoperoxyfumarate Terpolymer | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1992-07-28 | — | — | US | disclosed |
| US-5082912-A | For graft polymerization, surfactants | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1992-01-21 | — | — | US | disclosed |
| EP-0434362-A1 | Graft copolymer, solution containing the graft copolymer, and method of treating contact lens with the solution | Tomei Sangyo Kabushiki Kaisha (JP) | 1991-06-26 | — | — | EP | disclosed |
| EP-0433046-A2 | Polymer-type polymerization initiator | Tomei Sangyo Kabushiki Kaisha (JP) | 1991-06-19 | — | — | EP | disclosed |
| US-4868260-A | OXYGEN PERMEABILITY | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1989-09-19 | — | — | US | disclosed |
| EP-0219884-A2 | Hard contact lens material | Tomei Sangyo Kabushiki Kaisha (JP) | 1987-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12428390-B2 | Chromene compound and photochromic optical article | CRY1, CRY2, RAD51 | ATM 908/4885HCAR2 3379/4885MAPT 3558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.